DaVita HealthCare Partners Inc. (NYSE:DVA) shares fell 4.1% on Tuesday . The stock traded as low as $72.15 and last traded at $72.30, with a volume of 2,102,137 shares. The stock had previously closed at $75.36.

Several research firms have weighed in on DVA. Zacks Investment Research downgraded shares of DaVita HealthCare Partners from a “hold” rating to a “sell” rating in a report on Wednesday, July 27th. Wells Fargo & Co. reiterated a “buy” rating on shares of DaVita HealthCare Partners in a report on Saturday, June 4th. TheStreet upgraded shares of DaVita HealthCare Partners from a “hold” rating to a “buy” rating in a report on Wednesday, May 4th. Robert W. Baird reiterated a “buy” rating on shares of DaVita HealthCare Partners in a report on Sunday, May 8th. Finally, JPMorgan Chase & Co. increased their target price on shares of DaVita HealthCare Partners from $74.00 to $75.00 and gave the company a “neutral” rating in a report on Tuesday. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $78.00.

The firm has a market capitalization of $14.26 billion and a PE ratio of 40.58. The firm has a 50-day moving average price of $76.61 and a 200 day moving average price of $73.14.

DaVita HealthCare Partners (NYSE:DVA) last announced its earnings results on Monday, August 8th. The company reported $1.01 EPS for the quarter, beating the Zacks’ consensus estimate of $0.98 by $0.03. The business had revenue of $3.72 billion for the quarter, compared to the consensus estimate of $3.67 billion. During the same quarter last year, the firm posted $0.95 EPS. The business’s quarterly revenue was up 8.2% on a year-over-year basis. Equities research analysts expect that DaVita HealthCare Partners Inc. will post $3.80 EPS for the current fiscal year.

In other news, insider Jeanine Marie Jiganti sold 1,291 shares of DaVita HealthCare Partners stock in a transaction dated Monday, July 11th. The stock was sold at an average price of $78.51, for a total value of $101,356.41. Following the completion of the transaction, the insider now owns 5,716 shares of the company’s stock, valued at approximately $448,763.16. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Javier Rodriguez sold 36,466 shares of DaVita HealthCare Partners stock in a transaction dated Monday, May 16th. The stock was sold at an average price of $75.44, for a total value of $2,750,995.04. Following the completion of the transaction, the chief executive officer now directly owns 64,264 shares of the company’s stock, valued at approximately $4,848,076.16. The disclosure for this sale can be found here.

Several institutional investors recently bought and sold shares of the company. Advantus Capital Management Inc raised its position in DaVita HealthCare Partners by 0.6% in the fourth quarter. Advantus Capital Management Inc now owns 15,975 shares of the company’s stock valued at $1,114,000 after buying an additional 92 shares in the last quarter. I.G. Investment Management LTD. raised its position in DaVita HealthCare Partners by 28.4% in the fourth quarter. I.G. Investment Management LTD. now owns 17,802 shares of the company’s stock valued at $1,241,000 after buying an additional 3,939 shares in the last quarter. Pittenger & Anderson Inc. raised its position in DaVita HealthCare Partners by 93.2% in the fourth quarter. Pittenger & Anderson Inc. now owns 29,360 shares of the company’s stock valued at $2,047,000 after buying an additional 14,160 shares in the last quarter. Utah Retirement Systems raised its position in DaVita HealthCare Partners by 0.3% in the fourth quarter. Utah Retirement Systems now owns 31,618 shares of the company’s stock valued at $2,204,000 after buying an additional 100 shares in the last quarter. Finally, KBC Group NV raised its position in DaVita HealthCare Partners by 82.7% in the fourth quarter. KBC Group NV now owns 35,965 shares of the company’s stock valued at $2,507,000 after buying an additional 16,281 shares in the last quarter.

DaVita HealthCare Partners Inc is a provider of kidney care services. The Company operates Kidney Care division and HealthCare Partners (HCP) division. Its segments include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives. Its Kidney Care division is a provider of dialysis services in the United States, treating patients with chronic kidney failure and end stage renal disease (ESRD).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.